Annual Arnold O. Beckman conference in clinical chemistry. Charleston SC USA, 1995/02/05.
During the past quarter century, federal health policy makers concerned themselves with :
(a) improving the quality of healthcare delivered to the American public ;
(b) increasing access to needed healthcare services ;
and (c) curtailing the escalating cost of such services.
These goals led Congress to expand the role of the federal government in regulating the delivery of healthcare.
The enactment of the Clinical Laboratory Improvement Amendments of 1988 (CLIA'88) was a significant and widely discussed example of how Congress, when controlled by the Democrats, sought to correct healthcare problems and achieve federal objectives.
In November 1994, the Republicans won majorities in both the Senate and the House, promising to reduce the federal government's power.
Many now believe that CLIA'88, or significant parts of it, could be substantially modified as part of this effort.
This paper addresses the developments that led the Democrats to seek enactment of CLIA'88 and the likely arguments that may be offered by the Republicans to lessen the rigor and scope of the law.
Mots-clés Pascal : Biologie clinique, Réglementation, Gouvernement, Politique sanitaire, Etats Unis, Système santé, Législation, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Clinical biology, Regulation, Government, Health policy, United States, Health system, Legislation, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0496239
Code Inist : 002B30A09. Création : 01/03/1996.